2 days Ago By Defense World Staff
American Century Companies Inc. increased its position in shares of The Chemours Company ( NYSE:CC – Free Report ) by 26.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission.
The firm owned 1,811,957 shares of the specialty chemicals company’s stock after acquiring an additional 382,100 shares during the period. American Century Companies Inc. owned approximately 1.
22% of Chemours worth $40,896,000 as of its most recent filing with the Securities and Exchange Commission. Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Headlands Technologies LLC grew its position in Chemours by 315.
8% during the second quarter. Headlands Technologies LLC now owns 6,641 shares of the specialty chemicals company’s stock valued at $150,000 after acquiring an additional 5,044 shares during the last quarter. SIR Capital Management L.
P. grew its holdings in shares of Chemours by 51.4% during the 2nd quarter.
SIR Capital Management L.P. now owns 595,435 shares of the specialty chemicals company’s stock valued at $13,439,000 after purchasing an additional 202,054 shares during the last quarter.
LGT Fund Management Co Ltd. lifted its stake in Chemours by 79.4% in the second quarter.
LGT Fund Management Co Ltd. now owns 229,483 shares of the specialty chemicals company’s stock worth $5,179,000 after purchasing an additional 101,538 shares during the last quarter. Texas Permanent School Fund Corp boosted its position in Chemours by 12.
0% during the second quarter. Texas Permanent School Fund Corp now owns 145,289 shares of the specialty chemicals company’s stock valued at $3,279,000 after buying an additional 15,527 shares during the period. Finally, Private Management Group Inc.
grew its stake in shares of Chemours by 2.0% during the second quarter. Private Management Group Inc.
now owns 456,772 shares of the specialty chemicals company’s stock valued at $10,309,000 after buying an additional 9,057 shares during the last quarter. 76.26% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades A number of equities research analysts have recently weighed in on CC shares. JPMorgan Chase & Co. lowered their target price on Chemours from $25.
00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, August 6th. Barclays cut their target price on shares of Chemours from $30.
00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 6th. Mizuho started coverage on shares of Chemours in a research note on Friday, June 7th.
They issued a “neutral” rating and a $25.00 target price on the stock. UBS Group dropped their price target on shares of Chemours from $30.
00 to $28.00 and set a “buy” rating for the company in a research report on Tuesday, August 6th. Finally, BMO Capital Markets decreased their price objective on shares of Chemours from $35.
00 to $30.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 6th. Six analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock.
Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $26.75. Chemours Trading Up 0.
4 % Shares of CC opened at $18.03 on Tuesday. The firm’s 50-day moving average price is $20.
44 and its 200-day moving average price is $23.94. The company has a current ratio of 1.
89, a quick ratio of 1.01 and a debt-to-equity ratio of 5.45.
The firm has a market capitalization of $2.69 billion, a price-to-earnings ratio of -8.31 and a beta of 1.
74. The Chemours Company has a 1-year low of $15.10 and a 1-year high of $32.
70. Chemours ( NYSE:CC – Get Free Report ) last issued its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported $0.
38 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.19).
Chemours had a net margin of 2.16% and a return on equity of 33.21%.
The company had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.53 billion.
During the same quarter in the previous year, the business earned $1.10 earnings per share. Chemours’s revenue was down 6.
4% compared to the same quarter last year. Sell-side analysts anticipate that The Chemours Company will post 1.33 EPS for the current year.
Chemours Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Thursday, August 15th were issued a dividend of $0.25 per share.
The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.00 dividend on an annualized basis and a yield of 5.
55%. Chemours’s dividend payout ratio is currently -46.08%.
Chemours Profile ( Free Report ) The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Recommended Stories Five stocks we like better than Chemours What Are Dividend Achievers? An Introduction Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible What is MarketRankTM? How to Use it Roblox’s Growth Beyond Kids: Stock Set for Major Moves Best ESG Stocks: 11 Best Stocks for ESG Investing 5 Oversold Stocks to Buy Right Now Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company ( NYSE:CC – Free Report ). Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.
com's FREE daily email newsletter ..
